HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

New Ruipeng Pet Group / Equity Capital Markets

<ul>
<li>Pet medical industry is the second largest core industry after pet food industry.Pet hospital,with dual attributes of medical treatment and consumption,represents the direction of consumption upgrading and has huge potential.</li>
<li>New Ruipeng maintained rapid growth these years, but its business is still in the investment period. The Company is hard to generate high profit/returns due to low gross margin level.</li>
<li>There’re still technical bottlenecks in China.If New Ruipeng can fill these market gaps in time and provide comprehensive pet medical solutions, its development space and moat will be much higher.</li>
</ul>


Pet medical industry is the second largest core industry after pet food industry.Pet hospital,with dual attributes of medical treatment and consumption,represents the direction of consumption upgrading and has huge potential.
New Ruipeng maintained rapid growth these years, but its business is still in the investment period. The Company is hard to generate high profit/returns due to low gross margin level.
There’re still technical bottlenecks in China.If New Ruipeng can fill these market gaps in time and provide comprehensive pet medical solutions, its development space and moat will be much higher.


Pre-IPO New Ruipeng Pet Group (RPET.US)- The Industry, the Business and the Concerns

United States

New Ruipeng Pet Group Inc. operates as a holding company. The Company, through its subsidiaries, provides pet care service and sales of pet products. New Ruipeng Pet Group serves customers in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

New Ruipeng Pet Group (RPET US)

Pre-IPO New Ruipeng Pet Group (RPET.US)- The Industry, the Business and the Concerns

Pet hospital, with dual attributes of medical treatment and consumption, has huge development potential. New Ruipeng has rapid growth, but low...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)